Francois Rochon - Giverny Capital Inc.
Holding/activity history for Novo Nordisk A S (NVO)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 12,400 | 0.02 | $36.75 | $455,700 | SEC | ||
| 2025 Q4 | 12,400 | 0.02 | $50.88 | $630,912 | SEC | ||
| 2025 Q3 | 12,400 | 0.02 | $55.49 | $688,076 | SEC | ||
| 2025 Q2 | 12,400 | 0.03 | $69.02 | $855,848 | SEC | ||
| 2025 Q1 | 12,400 | 0.03 | $69.44 | $861,056 | SEC | ||
| 2024 Q4 | 12,400 | 0.04 | $86.02 | $1,066,648 | SEC | ||
| 2024 Q3 | 12,400 | 0.06 | $119.07 | $1,476,468 | SEC | ||
| 2024 Q2 | 12,400 | 0.07 | $142.74 | $1,769,976 | SEC | ||
| 2024 Q1 | 12,400 | 0.06 | $128.40 | $1,592,160 | SEC | ||
| 2023 Q4 | 12,400 | 0.06 | $103.45 | $1,282,780 | SEC | ||
| 2023 Q3 | 12,400 | 0.06 | Add 100.00% | 0.03 | $90.94 | $1,127,656 | SEC |
| 2023 Q2 | 6,200 | 0.05 | $161.83 | $1,003,346 | SEC | ||
| 2023 Q1 | 6,200 | 0.06 | $159.14 | $986,668 | SEC | ||
| 2022 Q4 | 6,200 | 0.05 | $135.34 | $839,108 | SEC | ||
| 2022 Q3 | 6,200 | 0.04 | $99.68 | $618,000 | SEC | ||
| 2022 Q2 | 6,200 | 0.05 | $111.45 | $691,000 | SEC | ||
| 2022 Q1 | 6,200 | 0.04 | $111.13 | $689,000 | SEC | ||
| 2021 Q4 | 6,200 | 0.04 | $111.94 | $694,000 | SEC | ||
| 2021 Q3 | 6,200 | 0.04 | $95.97 | $595,000 | SEC | ||
| 2021 Q2 | 6,200 | 0.03 | $83.71 | $519,000 | SEC | ||
| 2021 Q1 | 6,200 | 0.03 | $67.42 | $418,000 | SEC | ||
| 2020 Q4 | 6,200 | 0.03 | $0.07 | $433 | SEC | ||
| 2020 Q3 | 6,200 | 0.04 | Buy | 0.04 | $69.35 | $430,000 | SEC |